ASHLEY SCAGLIONE: Open Payments
NPI 1538618285 · HILLSBORO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 96 payments from 21 companies in 2025. Trend: 2023 $1,361 · 2024 $745 · 2025 $1,904
Food & beverage: $1,827Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $316 |
| Novo Nordisk Inc | 11 | $201 |
| Lilly USA, LLC | 8 | $177 |
| PFIZER INC. | 10 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $151 |
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| Amgen Inc. | 4 | $88 |
| Lundbeck LLC | 2 | $77 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
Products named: VRAYLAR, MOUNJARO, CAPLYTA, REXULTI, NURTEC ODT, Wegovy, AIRSUPRA, SHINGRIX.
Industry payments across MO — which companies pay providers there.
